Neuromuscular Blocking Agent (NMBA) Market Report

China Neuromuscular Blocking Agent (NMBA) Industry Market Research Report 2023-2029

  • POSTDATE：Aug 26, 2023
  • PAGES：144
  • REPORT CODE：GMM1756443
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Neuromuscular Blocking Agent (NMBA) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Guike Pharmaceutical

    • Sandoz

    • GlaxoSmithKline

    • Themis Medicare

    • Fresenius Kabi

    • Pfizer

    • Shanghai Pharmaceuticals

    • Nanjing King-Friend

    • Abbott Laboratories

    • Somerset Therapeutics

    By Type:

    • Non-depolarizing

    • Depolarizing

    By Application:

    • Clinic

    • Pharmacy

    • Hospital

    • Others

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Neuromuscular Blocking Agent (NMBA) Market Overview 2018-2029

    • 1.1 China Neuromuscular Blocking Agent (NMBA) Industry Development Overview

    • 1.2 China Neuromuscular Blocking Agent (NMBA) Industry Development History

    • 1.3 China Neuromuscular Blocking Agent (NMBA) Industry Market Size (2018-2029)

    • 1.4 China Neuromuscular Blocking Agent (NMBA) Market Analysis by Type from Production Side

      • 1.4.1 China Neuromuscular Blocking Agent (NMBA) Production Volume, Production Value and Growth Rate of Non-depolarizing (2018-2029)

      • 1.4.2 China Neuromuscular Blocking Agent (NMBA) Production Volume, Production Value and Growth Rate of Depolarizing (2018-2029)

    • 1.5 China Neuromuscular Blocking Agent (NMBA) Market Analysis by Application from Consumption End

      • 1.5.1 China Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

      • 1.5.2 China Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Growth Rate of Pharmacy (2018-2029)

      • 1.5.3 China Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

      • 1.5.4 China Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • 1.6 China Neuromuscular Blocking Agent (NMBA) Market Analysis by Region

      • 1.6.1 North China Neuromuscular Blocking Agent (NMBA) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Neuromuscular Blocking Agent (NMBA) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Neuromuscular Blocking Agent (NMBA) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Neuromuscular Blocking Agent (NMBA) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Neuromuscular Blocking Agent (NMBA) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Neuromuscular Blocking Agent (NMBA) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Neuromuscular Blocking Agent (NMBA) Market Size and Growth Rate from 2018-2029

    Chapter 2 China Neuromuscular Blocking Agent (NMBA) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Neuromuscular Blocking Agent (NMBA) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Neuromuscular Blocking Agent (NMBA) Market Status and Competition Analysis in 2023

      • 2.2.3 China Neuromuscular Blocking Agent (NMBA) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Neuromuscular Blocking Agent (NMBA) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Neuromuscular Blocking Agent (NMBA) Industry Development

    Chapter 3 Neuromuscular Blocking Agent (NMBA)Industry Chain Analysis

    • 3.1 Neuromuscular Blocking Agent (NMBA) Industry Chain

    • 3.2 Neuromuscular Blocking Agent (NMBA) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Neuromuscular Blocking Agent (NMBA) Market

    • 3.3 Neuromuscular Blocking Agent (NMBA) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Neuromuscular Blocking Agent (NMBA) Market

    Chapter 4 China Neuromuscular Blocking Agent (NMBA) Market, by Type

    • 4.1 China Neuromuscular Blocking Agent (NMBA) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Neuromuscular Blocking Agent (NMBA) Total Production Volume and Growth Rate from Production Side

    • 4.5 China Neuromuscular Blocking Agent (NMBA) Production Volume and Growth Rate, by Type

      • 4.5.1 China Neuromuscular Blocking Agent (NMBA) Production Volume and Growth Rate of Non-depolarizing

      • 4.5.2 China Neuromuscular Blocking Agent (NMBA) Production Volume and Growth Rate of Depolarizing

    Chapter 5 China Neuromuscular Blocking Agent (NMBA) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Neuromuscular Blocking Agent (NMBA) Total Market Size and Growth Rate from Consumption End

    • 5.5 China Neuromuscular Blocking Agent (NMBA) Market Size and Growth Rate, by Application

      • 5.5.1 China Neuromuscular Blocking Agent (NMBA) Market Size and Growth Rate of Clinic

      • 5.5.2 China Neuromuscular Blocking Agent (NMBA) Market Size and Growth Rate of Pharmacy

      • 5.5.3 China Neuromuscular Blocking Agent (NMBA) Market Size and Growth Rate of Hospital

      • 5.5.4 China Neuromuscular Blocking Agent (NMBA) Market Size and Growth Rate of Others

    Chapter 6 China Neuromuscular Blocking Agent (NMBA) Market, by Region

    • 6.1 China Neuromuscular Blocking Agent (NMBA) Production Volume and Production Value, by Region

    • 6.2 China Neuromuscular Blocking Agent (NMBA) Sales Volume and Sales Value, by Region

    Chapter 7 North China Neuromuscular Blocking Agent (NMBA) Market Analysis

    • 7.1 North China Neuromuscular Blocking Agent (NMBA) Market, by Type

    • 7.2 North China Neuromuscular Blocking Agent (NMBA) Market, by Application

    Chapter 8 Central China Neuromuscular Blocking Agent (NMBA) Market Analysis

    • 8.1 Central China Neuromuscular Blocking Agent (NMBA) Market, by Type

    • 8.2 Central China Neuromuscular Blocking Agent (NMBA) Market, by Application

    Chapter 9 South China Neuromuscular Blocking Agent (NMBA) Market Analysis

    • 9.1 South China Neuromuscular Blocking Agent (NMBA) Market, by Type

    • 9.2 South China Neuromuscular Blocking Agent (NMBA) Market, by Application

    Chapter 10 East China Neuromuscular Blocking Agent (NMBA) Market Analysis

    • 10.1 East China Neuromuscular Blocking Agent (NMBA) Market, by Type

    • 10.2 East China Neuromuscular Blocking Agent (NMBA) Market, by Application

    Chapter 11 Northeast China Neuromuscular Blocking Agent (NMBA) Market Analysis

    • 11.1 Northeast China Neuromuscular Blocking Agent (NMBA) Market, by Type

    • 11.2 Northeast China Neuromuscular Blocking Agent (NMBA) Market, by Application

    Chapter 12 Southwest China Neuromuscular Blocking Agent (NMBA) Market Analysis

    • 12.1 Southwest China Neuromuscular Blocking Agent (NMBA) Market, by Type

    • 12.2 Southwest China Neuromuscular Blocking Agent (NMBA) Market, by Application

    Chapter 13 Northwest China Neuromuscular Blocking Agent (NMBA) Market Analysis

    • 13.1 Northwest China Neuromuscular Blocking Agent (NMBA) Market, by Type

    • 13.2 Northwest China Neuromuscular Blocking Agent (NMBA) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Guike Pharmaceutical

        • 14.1.1 Guike Pharmaceutical Company Profile

        • 14.1.2 Guike Pharmaceutical Neuromuscular Blocking Agent (NMBA) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Sandoz

        • 14.2.1 Sandoz Company Profile

        • 14.2.2 Sandoz Neuromuscular Blocking Agent (NMBA) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 GlaxoSmithKline

        • 14.3.1 GlaxoSmithKline Company Profile

        • 14.3.2 GlaxoSmithKline Neuromuscular Blocking Agent (NMBA) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Themis Medicare

        • 14.4.1 Themis Medicare Company Profile

        • 14.4.2 Themis Medicare Neuromuscular Blocking Agent (NMBA) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Fresenius Kabi

        • 14.5.1 Fresenius Kabi Company Profile

        • 14.5.2 Fresenius Kabi Neuromuscular Blocking Agent (NMBA) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Pfizer

        • 14.6.1 Pfizer Company Profile

        • 14.6.2 Pfizer Neuromuscular Blocking Agent (NMBA) Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Shanghai Pharmaceuticals

        • 14.7.1 Shanghai Pharmaceuticals Company Profile

        • 14.7.2 Shanghai Pharmaceuticals Neuromuscular Blocking Agent (NMBA) Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Nanjing King-Friend

        • 14.8.1 Nanjing King-Friend Company Profile

        • 14.8.2 Nanjing King-Friend Neuromuscular Blocking Agent (NMBA) Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Abbott Laboratories

        • 14.9.1 Abbott Laboratories Company Profile

        • 14.9.2 Abbott Laboratories Neuromuscular Blocking Agent (NMBA) Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Somerset Therapeutics

        • 14.10.1 Somerset Therapeutics Company Profile

        • 14.10.2 Somerset Therapeutics Neuromuscular Blocking Agent (NMBA) Market Performance

        • 14.10.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Neuromuscular Blocking Agent (NMBA) Industry Research Conclusions

    • 15.2 Neuromuscular Blocking Agent (NMBA) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Neuromuscular Blocking Agent (NMBA) Industry Market Size (2018-2029)

    • Figure China Neuromuscular Blocking Agent (NMBA) Production Volume, Production Value and Growth Rate of Non-depolarizing (2018-2029)

    • Figure China Neuromuscular Blocking Agent (NMBA) Production Volume, Production Value and Growth Rate of Depolarizing (2018-2029)

    • Figure China Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

    • Figure China Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Growth Rate of Pharmacy (2018-2029)

    • Figure China Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure China Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure North China Neuromuscular Blocking Agent (NMBA) Market Size and Growth Rate from 2018-2029

    • Figure Central China Neuromuscular Blocking Agent (NMBA) Market Size and Growth Rate from 2018-2029

    • Figure South China Neuromuscular Blocking Agent (NMBA) Market Size and Growth Rate from 2018-2029

    • Figure East China Neuromuscular Blocking Agent (NMBA) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Neuromuscular Blocking Agent (NMBA) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Neuromuscular Blocking Agent (NMBA) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Neuromuscular Blocking Agent (NMBA) Market Size and Growth Rate from 2018-2029

    • Figure Neuromuscular Blocking Agent (NMBA) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Neuromuscular Blocking Agent (NMBA) Market Share by Type in 2018

    • Figure China Neuromuscular Blocking Agent (NMBA) Market Share by Type in 2023

    • Figure China Neuromuscular Blocking Agent (NMBA) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Neuromuscular Blocking Agent (NMBA) Production Volume and Growth Rate of Non-depolarizing (2018-2023)

    • Figure China Neuromuscular Blocking Agent (NMBA) Production Volume and Growth Rate of Depolarizing (2018-2023)

    • Figure China Neuromuscular Blocking Agent (NMBA) Market Share by Application in 2018

    • Figure China Neuromuscular Blocking Agent (NMBA) Market Share by Application in 2023

    • Figure China Neuromuscular Blocking Agent (NMBA) Total Market Size and Growth Rate from Consumption End

    • Figure China Neuromuscular Blocking Agent (NMBA) Market Size and Growth Rate of Clinic (2018-2023)

    • Figure China Neuromuscular Blocking Agent (NMBA) Market Size and Growth Rate of Pharmacy (2018-2023)

    • Figure China Neuromuscular Blocking Agent (NMBA) Market Size and Growth Rate of Hospital (2018-2023)

    • Figure China Neuromuscular Blocking Agent (NMBA) Market Size and Growth Rate of Others (2018-2023)

    • Table China Neuromuscular Blocking Agent (NMBA) Production Volume by Region (2018-2023)

    • Table China Neuromuscular Blocking Agent (NMBA) Production Volume Share by Region (2018-2023)

    • Figure China Neuromuscular Blocking Agent (NMBA) Production Volume Share by Region (2018-2023)

    • Table China Neuromuscular Blocking Agent (NMBA) Production Value by Region (2018-2023)

    • Table China Neuromuscular Blocking Agent (NMBA) Production Value Share by Region (2018-2023)

    • Figure China Neuromuscular Blocking Agent (NMBA) Production Value Share by Region (2018-2023)

    • Table China Neuromuscular Blocking Agent (NMBA) Sales Volume by Region (2018-2023)

    • Table China Neuromuscular Blocking Agent (NMBA) Sales Volume Share by Region (2018-2023)

    • Figure China Neuromuscular Blocking Agent (NMBA) Sales Volume Share by Region (2018-2023)

    • Table China Neuromuscular Blocking Agent (NMBA) Sales Value by Region (2018-2023)

    • Table China Neuromuscular Blocking Agent (NMBA) Sales Value Share by Region (2018-2023)

    • Figure China Neuromuscular Blocking Agent (NMBA) Sales Value Share by Region (2018-2023)

    • Table North China Neuromuscular Blocking Agent (NMBA) Production Volume by Type (2018-2023)

    • Table North China Neuromuscular Blocking Agent (NMBA) Production Volume Share by Type (2018-2023)

    • Figure North China Neuromuscular Blocking Agent (NMBA) Production Volume Share by Type (2018-2023)

    • Table North China Neuromuscular Blocking Agent (NMBA) Sales Volume by Application (2018-2023)

    • Table North China Neuromuscular Blocking Agent (NMBA) Sales Volume Share by Application (2018-2023)

    • Figure North China Neuromuscular Blocking Agent (NMBA) Sales Volume Share by Application (2018-2023)

    • Table Central China Neuromuscular Blocking Agent (NMBA) Production Volume by Type (2018-2023)

    • Table Central China Neuromuscular Blocking Agent (NMBA) Production Volume Share by Type (2018-2023)

    • Figure Central China Neuromuscular Blocking Agent (NMBA) Production Volume Share by Type (2018-2023)

    • Table Central China Neuromuscular Blocking Agent (NMBA) Sales Volume by Application (2018-2023)

    • Table Central China Neuromuscular Blocking Agent (NMBA) Sales Volume Share by Application (2018-2023)

    • Figure Central China Neuromuscular Blocking Agent (NMBA) Sales Volume Share by Application (2018-2023)

    • Table South China Neuromuscular Blocking Agent (NMBA) Production Volume by Type (2018-2023)

    • Table South China Neuromuscular Blocking Agent (NMBA) Production Volume Share by Type (2018-2023)

    • Figure South China Neuromuscular Blocking Agent (NMBA) Production Volume Share by Type (2018-2023)

    • Table South China Neuromuscular Blocking Agent (NMBA) Sales Volume by Application (2018-2023)

    • Table South China Neuromuscular Blocking Agent (NMBA) Sales Volume Share by Application (2018-2023)

    • Figure South China Neuromuscular Blocking Agent (NMBA) Sales Volume Share by Application (2018-2023)

    • Table East China Neuromuscular Blocking Agent (NMBA) Production Volume by Type (2018-2023)

    • Table East China Neuromuscular Blocking Agent (NMBA) Production Volume Share by Type (2018-2023)

    • Figure East China Neuromuscular Blocking Agent (NMBA) Production Volume Share by Type (2018-2023)

    • Table East China Neuromuscular Blocking Agent (NMBA) Sales Volume by Application (2018-2023)

    • Table East China Neuromuscular Blocking Agent (NMBA) Sales Volume Share by Application (2018-2023)

    • Figure East China Neuromuscular Blocking Agent (NMBA) Sales Volume Share by Application (2018-2023)

    • Table Northeast China Neuromuscular Blocking Agent (NMBA) Production Volume by Type (2018-2023)

    • Table Northeast China Neuromuscular Blocking Agent (NMBA) Production Volume Share by Type (2018-2023)

    • Figure Northeast China Neuromuscular Blocking Agent (NMBA) Production Volume Share by Type (2018-2023)

    • Table Northeast China Neuromuscular Blocking Agent (NMBA) Sales Volume by Application (2018-2023)

    • Table Northeast China Neuromuscular Blocking Agent (NMBA) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Neuromuscular Blocking Agent (NMBA) Sales Volume Share by Application (2018-2023)

    • Table Southwest China Neuromuscular Blocking Agent (NMBA) Production Volume by Type (2018-2023)

    • Table Southwest China Neuromuscular Blocking Agent (NMBA) Production Volume Share by Type (2018-2023)

    • Figure Southwest China Neuromuscular Blocking Agent (NMBA) Production Volume Share by Type (2018-2023)

    • Table Southwest China Neuromuscular Blocking Agent (NMBA) Sales Volume by Application (2018-2023)

    • Table Southwest China Neuromuscular Blocking Agent (NMBA) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Neuromuscular Blocking Agent (NMBA) Sales Volume Share by Application (2018-2023)

    • Table Northwest China Neuromuscular Blocking Agent (NMBA) Production Volume by Type (2018-2023)

    • Table Northwest China Neuromuscular Blocking Agent (NMBA) Production Volume Share by Type (2018-2023)

    • Figure Northwest China Neuromuscular Blocking Agent (NMBA) Production Volume Share by Type (2018-2023)

    • Table Northwest China Neuromuscular Blocking Agent (NMBA) Sales Volume by Application (2018-2023)

    • Table Northwest China Neuromuscular Blocking Agent (NMBA) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Neuromuscular Blocking Agent (NMBA) Sales Volume Share by Application (2018-2023)

    • Table Guike Pharmaceutical Company Profile

    • Table Guike Pharmaceutical Neuromuscular Blocking Agent (NMBA) Revenue, Price and Gross (2018-2023)

    • Table Sandoz Company Profile

    • Table Sandoz Neuromuscular Blocking Agent (NMBA) Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Company Profile

    • Table GlaxoSmithKline Neuromuscular Blocking Agent (NMBA) Revenue, Price and Gross (2018-2023)

    • Table Themis Medicare Company Profile

    • Table Themis Medicare Neuromuscular Blocking Agent (NMBA) Revenue, Price and Gross (2018-2023)

    • Table Fresenius Kabi Company Profile

    • Table Fresenius Kabi Neuromuscular Blocking Agent (NMBA) Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Neuromuscular Blocking Agent (NMBA) Revenue, Price and Gross (2018-2023)

    • Table Shanghai Pharmaceuticals Company Profile

    • Table Shanghai Pharmaceuticals Neuromuscular Blocking Agent (NMBA) Revenue, Price and Gross (2018-2023)

    • Table Nanjing King-Friend Company Profile

    • Table Nanjing King-Friend Neuromuscular Blocking Agent (NMBA) Revenue, Price and Gross (2018-2023)

    • Table Abbott Laboratories Company Profile

    • Table Abbott Laboratories Neuromuscular Blocking Agent (NMBA) Revenue, Price and Gross (2018-2023)

    • Table Somerset Therapeutics Company Profile

    • Table Somerset Therapeutics Neuromuscular Blocking Agent (NMBA) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US